Balyasny Asset Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,289
| Closed | -$274K | – | 2322 |
|
|
2025
Q1 | $274K | Buy |
+22,289
| New | +$274K | ﹤0.01% | 1738 |
|
|
2024
Q2 | – | Sell |
-26,950
| Closed | -$356K | – | 2260 |
|
|
2024
Q1 | $356K | Sell |
26,950
-206
| -0.8% | -$2.72K | ﹤0.01% | 1600 |
|
|
2023
Q4 | $280K | Buy |
+27,156
| New | +$280K | ﹤0.01% | 1636 |
|